Posted On: 01/07/2016 12:04:23 PM
Post# of 72444
All this by June 30 2016...IMPRESSIVE!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1. Start of Kevetrin advanced study in ovarian cancer.
2. Start of Brilacidin ABSSSI Phase 3
3. Start of Brilacidin for Ulcerative Proctitis proof of concept trial
(phase 2)
4. Top line data on Kevetrin Phase 1 trial for advanced solid tumors
5. Top line data on Prurisol Phase 2 trial for chronic plaque psoriasis
6. Interim analysis for Brilacidin Phase 2 trial for Oral Mucositis
7. Start of Retinoblastoma program, formulation and toxicity studies
8. Additional ototoxicity studies with Brilacidin in different
concentrations
9. Gram- negative and anti-fungal progress
10. Submission of grant application for study of Kevetrin in Pancreatic
cancer with renowned hospital.
1. Start of Kevetrin advanced study in ovarian cancer.
2. Start of Brilacidin ABSSSI Phase 3
3. Start of Brilacidin for Ulcerative Proctitis proof of concept trial
(phase 2)
4. Top line data on Kevetrin Phase 1 trial for advanced solid tumors
5. Top line data on Prurisol Phase 2 trial for chronic plaque psoriasis
6. Interim analysis for Brilacidin Phase 2 trial for Oral Mucositis
7. Start of Retinoblastoma program, formulation and toxicity studies
8. Additional ototoxicity studies with Brilacidin in different
concentrations
9. Gram- negative and anti-fungal progress
10. Submission of grant application for study of Kevetrin in Pancreatic
cancer with renowned hospital.
(0)
(0)Scroll down for more posts ▼
